![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | C07D 487/04 | (2006.01) |
A61K 31/52 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Patento numeris | 3091020 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 16159438.7 |
Europos patento paraiškos padavimo data | 2010-05-13 | |
(97) | Europos patento paraiškos paskelbimo data | 2016-11-09 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2020-12-30 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
216221 P | 2009-05-14 | US |
(72) |
Armitage, Ian, G, US
Chopra, Reenu, GB
Cooper, Martin, Ian, GB
Langston, Marianne, US
Langston, Steven P., US
Vyskocil, Stepan, US
|
(73) |
Takeda Pharmaceutical Company Limited ,
1-1, Doshomachi 4-chome,
Chuo-ku,, Osaka-shi, Osaka,
JP
|
(54) | HYDROCHLORIDE SALT OF ((1S,2S,4R)-4-{4-[(1S)-2,3-DIHYDRO-1H-INDEN-1-YLAMINO]-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL}-2-HYDROXYCYCLOPENTYL)METHYL SULFAMATE |
HYDROCHLORIDE SALT OF ((1S,2S,4R)-4-{4-[(1S)-2,3-DIHYDRO-1H-INDEN-1-YLAMINO]-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL}-2-HYDROXYCYCLOPENTYL)METHYL SULFAMATE |